ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CCM For Pharmacies: Physician Collaboration Model For New Revenue Announced

CCM RPM Help has announced a pharmacy-physician collaboration model that turns routine clinical work into Medicare-reimbursable income. Pharmacies managing chronic care patients can gain predictable monthly revenue, stronger physician relationships, and measurable patient outcomes — without restructuring their current operations.

-- CCM RPM Help has announced a structured partnership model that connects pharmacies with physicians to deliver Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) programs. Created to strengthen independent pharmacies' financial position without disrupting daily operations, the model offers a path to monetize the clinical support pharmacy teams already provide.

For more information or to schedule a consultation, visit: https://ccmrpmhelp.com/

The timing of the launch addresses a pressing need, the team explains. Shrinking margins and rising chargebacks continue to erode profitability for independent pharmacies, while few reliable options exist to replace lost revenue. Against that backdrop, CCM RPM Help presents a model built not around reinvention, but around recognition—Medicare allows pharmacy-physician collaboration as a legitimate care coordination structure, meaning pharmacies can participate in compliant, billable services through an established framework.

That framework rests on a clear division of responsibility: pharmacies take the lead in patient engagement, while a supervising physician bills for the care delivered. CCM RPM Help supports the partnership from end to end—establishing the required clinical relationships, building compliant workflows, training pharmacy staff, and overseeing documentation and billing. With that infrastructure in place, pharmacies can enter the program without adding staff or overhauling existing operations.

What makes the model especially practical is that many of the qualifying activities are already part of the pharmacy team’s routine. Speaking with patients about medications, checking in with providers, monitoring blood pressure or glucose readings, and coordinating with caregivers are all familiar responsibilities. Under CCM and RPM, those same touchpoints can be formalized into a reimbursable care model. Each enrolled patient contributes toward monthly reimbursement thresholds, while RPM device reimbursement can create an additional layer of earning potential.

A representative from CCM RPM Help noted that pharmacies often serve as the most consistent point of contact for patients living with chronic conditions. The new model's role, the representative explained, is to transform that ongoing engagement into a compliant, billable structure that allows pharmacies to earn alongside their physician partners for the care they are already delivering every day.

The value of the model extends beyond revenue alone. Active pharmacy participation in CCM and RPM has been linked to better medication adherence, fewer emergency visits, and stronger patient satisfaction. Those outcomes not only improve care but also strengthen the pharmacy’s value to referring physicians, helping build collaborative relationships that can support long-term program growth, the team says.

To make that possible, CCM RPM Help provides the full operational foundation, including templates, compliance oversight, reporting dashboards, and ongoing support. Pharmacies ready to formalize their clinical role and build a more predictable income stream can connect directly with the team at https://ccmrpmhelp.com/contact

Contact Info:
Name: Brad Klekas
Email: Send Email
Organization: CCM RPM Help
Address: 12953 Penywain Lane, Herriman, Utah 84096, United States
Phone: +1-866-574-7075
Website: https://ccmrpmhelp.com/

Source: NewsNetwork

Release ID: 89185705

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.24
-2.90 (-1.38%)
AAPL  251.64
+0.15 (0.06%)
AMD  205.37
+2.69 (1.33%)
BAC  48.14
+0.62 (1.30%)
GOOG  289.20
-9.82 (-3.28%)
META  592.92
-11.14 (-1.84%)
MSFT  372.74
-10.26 (-2.68%)
NVDA  175.20
-0.44 (-0.25%)
ORCL  147.09
-7.25 (-4.70%)
TSLA  383.03
+2.18 (0.57%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.